FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

New research suggests conservation efforts could more effectively identify and protect bird species at greatest risk from climate change by better understanding the range of specific conditions they ...

New research revealed the remarkable chemical diversity of substances exuded by coral reefs and demonstrated that thousands of different chemicals derived from tropical corals and seaweeds are ...

A study has shown that Europe has adapted better to low temperatures than to high temperatures over the last two decades. The relative risk of mortality at the coldest temperatures has decreased by 2% ...

New technology could enable more sustainable and cheaper production of bio-oils to replace petroleum-based products in electronic, construction and automotive applications. The technology, known as ...

Agronomists question statistical methods used to predict yield potential and 'yield gaps' for major crops. In some cases, yield potential is overestimated, while in others it can be underestimated.

In a massive scientific effort, hundreds of researchers have helped to map the connections between hundreds of thousands of neurons in the mouse brain and then overlayed their firing patterns in ...

It's a game a lot of us played as children -- and maybe even later in life: unspooling measuring tape to see how far it would extend before bending. But to engineer, this game was an inspiration, ...

Astronomers are investigating the longest and most energetic bursts of X-rays seen from a newly awakened black hole. Watching this strange behavior unfold in real time offers a unique opportunity to ...

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...